Straits Times Index
3,257.99 -25.36 (-0.77%) Nikkei
27,113.13 -475.24 (-1.72%) Hang Seng
24,656.46 0.00 (0.00%) FTSE 100
7,297.15 -196.98 (-2.63%) BTC-USD
36,087.52 +109.62 (+0.30%) CMC Crypto 200
821.53 +10.93 (+1.35%)
Abbott Laboratories (ABT)
After hours:
- Zacks
Is a Surprise Coming for Abbott (ABT) This Earnings Season?
Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Abbott is a major pharmaceutical company best known for its medical devices, diagnostics, and pediatric and adult nutritional products -- think Pedialyte or Similac. This year, it's being crowned as a dividend king -- meaning the company has increased its annual dividend for 50 consecutive years. Excluding COVID-testing-related sales, Abbott still boasts a nearly 12% increase over pre-pandemic 2019 sales for the quarter.
- Motley Fool
3 Things About Abbott Laboratories That Smart Investors Know
When it comes to underrated healthcare stocks that smart investors love, Abbott Laboratories (NYSE: ABT) takes the cake. On the contrary, it's exactly Abbott's willingness to compete in these spaces that makes the company one of the sturdiest. Given that Abbott has a market cap of about $238 billion and trailing revenue of $42.3 billion, it shouldn't surprise anyone that the business sometimes struggles to grow as aggressively as a smaller competitor might.
